HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $1.77M invested in Hepion Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$69.7K |
2 |
VF
Virtu Financial
New York
|
-$41K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.47K |
4 |
Morgan Stanley
New York
|
-$3.88K |
5 |
![]()
JPMorgan Chase & Co
New York
|
-$3.61K |